Removes rating changes with wrong date

ZURICH/GDANSK, June 3 (Reuters) -Here are some of the main factors that may affect Swiss stocks on Monday:

UBS UBSG.S

UBS on Friday completed the merger of the main parent companies of the Swiss bank and Credit Suisse, which it acquired last year after its longtime rival collapsed, putting an end to one of the bastions of the country's financial sector.

MOLECULAR PARTNERS MOLN.S

Molecular Partners presents positive data from completed phase 1 trial of mp0317 monotherapy in patients with advanced solid tumors.

GLENCORE GLEN.L

A majority of Glencore investors have indicated they were satisfied with the commodities giant's plans to reduce carbon emissions, just as it gets closer to completing its acquisition of Teck Resources' steelmaking coal business.

NOVARTIS NOVN.S

Novartis says phase III trial shows Kisqali product reduces risk of cancer recurrence for early breast cancer patients with high-risk node-negative disease.

ANALYSTS' VIEWS

There are no rating changes from today.

ECONOMY

Swiss May manufacturing PMI due at 0730 GMT.

SNB data on Swiss sight deposits due at 0800 GMT.

Reporting by Zurich newsroom and Gdansk newsroom

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH 
All equity news E

SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS